These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27930716)

  • 1. MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response.
    Ho V; Chung L; Revoltar M; Lim SH; Tut TG; Abubakar A; Henderson CJ; Chua W; Ng W; Lee M; De Souza P; Morgan M; Lee CS; Shin JS
    PLoS One; 2016; 11(12):e0167675. PubMed ID: 27930716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis.
    Ho V; Chung L; Singh A; Lea V; Abubakar A; Lim SH; Ng W; Lee M; de Souza P; Shin JS; Lee CS
    BMC Cancer; 2018 Sep; 18(1):869. PubMed ID: 30176843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.
    Laurberg JR; Brems-Eskildsen AS; Nordentoft I; Fristrup N; Schepeler T; Ulhøi BP; Agerbaek M; Hartmann A; Bertz S; Wittlinger M; Fietkau R; Rödel C; Borre M; Jensen JB; Orntoft T; Dyrskjøt L
    BJU Int; 2012 Dec; 110(11 Pt C):E1228-36. PubMed ID: 23046361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.
    Choudhury A; Nelson LD; Teo MT; Chilka S; Bhattarai S; Johnston CF; Elliott F; Lowery J; Taylor CF; Churchman M; Bentley J; Knowles MA; Harnden P; Bristow RG; Bishop DT; Kiltie AE
    Cancer Res; 2010 Sep; 70(18):7017-26. PubMed ID: 20843819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
    Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J
    World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
    Shen L; Wang L; Li G; Zhang H; Liang L; Fan M; Wu Y; Deng W; Sheng W; Zhu J; Zhang Z
    Clin Transl Oncol; 2016 Jul; 18(7):693-9. PubMed ID: 26527031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience.
    Patel UB; Taylor F; Blomqvist L; George C; Evans H; Tekkis P; Quirke P; Sebag-Montefiore D; Moran B; Heald R; Guthrie A; Bees N; Swift I; Pennert K; Brown G
    J Clin Oncol; 2011 Oct; 29(28):3753-60. PubMed ID: 21876084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy.
    Nougaret S; Rouanet P; Molinari N; Pierredon MA; Bibeau F; Azria D; Lemanski C; Assenat E; Duffour J; Ychou M; Reinhold C; Gallix B
    Radiology; 2012 May; 263(2):409-18. PubMed ID: 22438364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.
    Bouzourene H; Bosman FT; Seelentag W; Matter M; Coucke P
    Cancer; 2002 Feb; 94(4):1121-30. PubMed ID: 11920483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
    Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
    Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of MRE11 Overexpression in Colorectal Cancer Patients.
    Ho V; Chung L; Wilkinson K; Lea V; Lim SH; Abubakar A; Ng W; Lee M; Roberts TL; Chua W; Lee CS
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival.
    Voboril R; Rychterova V; Voborilova J; Kubecova M; Fanta J; Dvorak J
    Neoplasma; 2016; 63(3):462-70. PubMed ID: 26952512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
    Yao YF; Du CZ; Chen N; Chen P; Gu J
    Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Duration of Neoadjuvant Radiation on Rectal Cancer Survival: A Real World Multi-center Retrospective Cohort Study.
    Abdel-Rahman O; Kumar A; Kennecke HF; Speers CH; Cheung WY
    Clin Colorectal Cancer; 2018 Mar; 17(1):e21-e28. PubMed ID: 28709877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer.
    Suh KJ; Ryu HS; Lee KH; Kim H; Min A; Kim TY; Yang Y; Moon HG; Han SW; Oh DY; Han W; Park IA; Noh DY; Im SA
    Breast Cancer Res Treat; 2016 Jul; 158(2):233-41. PubMed ID: 27329169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mandard tumour regression grade, perineural invasion, circumferential resection margin and post-chemoradiation nodal status strongly predict outcome in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
    Dhadda AS; Bessell EM; Scholefield J; Dickinson P; Zaitoun AM
    Clin Oncol (R Coll Radiol); 2014 Apr; 26(4):197-202. PubMed ID: 24485884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T3 subclassification using the EMD/mesorectum ratio predicts neoadjuvant chemoradiation outcome in T3 rectal cancer patients.
    Shen L; Sun Y; Zhang H; Zhang J; Deng W; Wang Y; Yao Y; Yang L; Zhu J; Tong T; Liang L; Zhang Z
    Br J Radiol; 2018 Jan; 91(1081):20170617. PubMed ID: 29072488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.
    Yuan SS; Hou MF; Hsieh YC; Huang CY; Lee YC; Chen YJ; Lo S
    J Natl Cancer Inst; 2012 Oct; 104(19):1485-502. PubMed ID: 22914783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
    Zhang LN; Xiao WW; Xi SY; OuYang PY; You KY; Zeng ZF; Ding PR; Zhang HZ; Pan ZZ; Xu RH; Gao YH
    Oncotarget; 2016 Feb; 7(5):6335-44. PubMed ID: 26695441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.